Bass A S, Robie N W
J Pharmacol Exp Ther. 1984 Apr;229(1):67-71.
The stereoselectivity of S (S)- and R (R)-sulpiride for the pre-(prereceptor) and post (postreceptor) synaptic dopamine receptors has been examined in various tissues. In the present study, the effects of S and R on the pre- and postreceptor in the canine kidney were investigated. The left renal artery of pentobarbital-anesthetized dogs was exposed and mean arterial pressure and renal blood flow were monitored. Vasoconstrictor stimuli [nerve stimulation: 1-8 Hz, 2 msec, 10-20 V, 5 sec; norepinephrine: 0.25-1.0 micrograms i.a.] were produced before and during graded doses of dopamine (DA: 0.3-2.4 micrograms/kg/min i.a.) administration. After a 15-minute recovery period, vasoconstrictor stimuli were repeated before and during the reinfusion of DA at the 2.4-micrograms/kg/min dose. While continuing DA, S or R (0.06-15.6 micrograms/kg/min) was administered and vasoconstrictor stimuli were repeated. DA antagonized the response to nerve stimulation but not norepinephrine (P less than .05). This effect of DA was antagonized by S at a dose of 0.12 micrograms/kg/min but not R. S and R alone did not affect the response to nerve stimulation. In dogs pretreated with phenoxybenzamine (5 mg/kg i.a.), DA produced a decrease in renal vascular resistance (P less than .05) and a dose of 15.6 micrograms/kg/min of either S or R was required to block this effect of DA. Therefore, S is 130 times more stereoselective for the prereceptor, whereas S and R are equipotent at the postreceptor in the canine kidney.
已在多种组织中研究了S(S)-和R(R)-舒必利对突触前(受体前)和突触后(受体后)多巴胺受体的立体选择性。在本研究中,研究了S型和R型舒必利对犬肾中受体前和受体后的影响。暴露戊巴比妥麻醉犬的左肾动脉,并监测平均动脉压和肾血流量。在分级剂量的多巴胺(DA:0.3 - 2.4微克/千克/分钟,经动脉注射)给药前和给药期间,施加血管收缩刺激[神经刺激:1 - 8赫兹,2毫秒,10 - 20伏,5秒;去甲肾上腺素:0.25 - 1.0微克,经动脉注射]。在15分钟的恢复期后,在以2.4微克/千克/分钟的剂量重新输注DA之前和期间,重复血管收缩刺激。在持续给予DA的同时,给予S或R(0.06 - 15.6微克/千克/分钟),并重复血管收缩刺激。DA拮抗对神经刺激的反应,但不拮抗去甲肾上腺素(P < 0.05)。S型舒必利以0.12微克/千克/分钟的剂量可拮抗DA的这种作用,而R型则不能。单独的S型和R型舒必利不影响对神经刺激的反应。在用酚苄明(5毫克/千克,经动脉注射)预处理的犬中,DA导致肾血管阻力降低(P < 0.05),需要15.6微克/千克/分钟的S型或R型舒必利才能阻断DA的这种作用。因此,S型对受体前的立体选择性比R型高130倍,而在犬肾中,S型和R型在受体后是等效的。